- 09:25 - 20/03/2024 to 16:05 - 20/03/2024
- Cavendish Conference Centre, 22 Duchess Mews, London, W1G 9DT, United Kingdom
The theme of this hybrid meeting is Controversies and uncertainties – Unanswered questions in myeloma. The Michael Morley Lecture – Bispecific Abs and CAR-T: sequencing toxicities and practicalities – will be delivered by Professor Niels van der Donk, Amsterdam University Medical Centre.
TOPICS COVERED
Presentations from guest speakers with sessions -
What now for ASCT in myeloma?, Debate: Role of 1st ASCT - do we still need it at all?, Michael Morley Lecture, Debate: Early Treatment vs 'monitoring' in biochemical relapse, Debate: Should we treat high risk smouldering myeloma?
WHO SHOULD ATTEND?
Suitable for Consultants, Trainees, Nurses, Scientists, Pharmacists and anyone working in the field of myeloma.
SPEAKERS
- Dr Sally Moore
- Dr Andrew Charlton
- Dr Jonathan Sive
- Dr Rakesh Popat
- Dr Kirsty Cuthill
- Dr Ceri Bygrave
- Professor Guy Pratt
- Dr Matthew Jenner
- Prof Niels van der Donk
- Dr Charlotte Pawlyn
- Dr Emma Searle
- Dr Dean Smith
- Dr Jaimal Kothari
For more information, please contact: [email protected]